Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
December 04, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
November 28, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Infusion Therapy Devices Market to Rise Ahead Due to Global Increase in Elderly Population – IndustryARC Research
March 11, 2017 11:00 ET
|
IndustryARC
Hyderabad, India, March 11, 2017 (GLOBE NEWSWIRE) -- The report “Infusion Therapy Devices Market: By Type(Infusion Method, Operation Type, Infusion Type) By Types of Infusion Pumps (Large Volume...
Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank
August 08, 2016 05:30 ET
|
Sunshine Heart, Inc.
EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc....